Enlight Renewable Energy Ltd.·4

May 26, 7:26 AM ET

SEROUSSI YAIR 4

4 · Enlight Renewable Energy Ltd. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Enlight (ENLT) Vice Chair Yair Seroussi Exercises Options, Sells Shares

What Happened

  • Yair Seroussi, Vice Chairman of the Board of Enlight Renewable Energy (ENLT), exercised 20,000 derivative awards on May 25, 2026 (5,000 + 15,000 at $23.22) for a total exercise cost of $464,400.
  • Immediately following the exercises he disposed of the exercised shares: 14,372 shares were sold in open-market transactions (3,593 @ $94.24 and 10,779 @ $93.04) generating $1,341,482 in proceeds. An additional 5,628 shares (1,407 + 4,221) were retained/withheld to cover the exercise price and tax liability, valued at $525,318.
  • The net result: 20,000 shares were acquired by exercise and 20,000 shares were disposed (combination of market sales and tax/exercise withholding). Two additional derivative entries showing 5,000 and 15,000 shares at $0.00 are included in the filing for informational purposes.

Key Details

  • Transaction date: May 25, 2026; Form 4 filed May 26, 2026 (filing flagged as late).
  • Exercise price(s): $23.22 per share (conversion from NIS per footnote F1).
  • Open-market sales: 3,593 shares @ $94.24 = $338,604; 10,779 shares @ $93.04 = $1,002,878.
  • Shares withheld for taxes/exercise: 1,407 @ $94.24 = $132,596; 4,221 @ $93.04 = $392,722.
  • Total proceeds from open-market sales: $1,341,482. Total value of shares withheld to cover taxes/exercise: $525,318. Total exercise cost: $464,400.
  • Shares owned after transaction: not specified in the filing.
  • Notable footnotes: F1 (NIS→USD conversion), F3 (company retained shares to pay exercise price), F9 (some derivative entries included for informational purposes), F2/F10 (existence of RSU/PSU programs described elsewhere in the filing).

Context

  • This was an option exercise followed by immediate dispositions — a common cashless or partially cashless exercise structure where some shares are sold to cover exercise costs and taxes. Such transactions are routine for option-bearing insiders and do not by themselves indicate a change in company outlook.
  • The filing was flagged late (L), which affects timeliness/transparency but does not change the reported economic details.

Insider Transaction Report

Form 4
Period: 2026-05-25
SEROUSSI YAIR
DirectorOther
Transactions
  • Exercise/Conversion

    Ordinary shares, NIS 0.1 par value per share

    [F1][F2]
    2026-05-25$23.22/sh+5,000$116,10019,233 total
  • Tax Payment

    Ordinary shares, NIS 0.1 par value per share

    [F3][F4][F2]
    2026-05-25$94.24/sh1,407$132,59617,826 total
  • Sale

    Ordinary shares, NIS 0.1 par value per share

    [F4][F2]
    2026-05-25$94.24/sh3,593$338,60414,233 total
  • Exercise/Conversion

    Ordinary shares, NIS 0.1 par value per share

    [F1][F2]
    2026-05-25$23.22/sh+15,000$348,30029,233 total
  • Tax Payment

    Ordinary shares, NIS 0.1 par value per share

    [F3][F5][F2]
    2026-05-25$93.04/sh4,221$392,72225,012 total
  • Sale

    Ordinary shares, NIS 0.1 par value per share

    [F5][F2]
    2026-05-25$93.04/sh10,779$1,002,87814,233 total
  • Exercise/Conversion

    Stock Options (right to buy)

    [F1][F6]
    2026-05-255,00031,000 total
    Exercise: $23.22Exp: 2028-09-30Ordinary shares, NIS 0.1 par value per share (5,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    [F1][F6]
    2026-05-2515,00016,000 total
    Exercise: $23.22Exp: 2028-09-30Ordinary shares, NIS 0.1 par value per share (15,000 underlying)
Holdings
  • Stock Options (right to buy)

    [F7][F8][F9]
    Exercise: $27.33Exp: 2032-10-01Ordinary shares, NIS 0.1 par value per share (51,574 underlying)
    51,574
  • Performance-Based RSUs

    [F10][F9]
    Ordinary shares, NIS 0.1 par value per share (11,339 underlying)
    11,339
Footnotes (10)
  • [F1]Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  • [F10]Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
  • [F2]Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
  • [F3]These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
  • [F4]Represents a transaction price of NIS 273.97, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  • [F5]Represents a transaction price of NIS 270.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.
  • [F6]Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.
  • [F7]Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
  • [F8]Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029.
  • [F9]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Signature
/s/ Helit Megido as attorney-in-fact for Yair Seroussi|2026-05-26

Documents

1 file
  • 4
    ownership.xmlPrimary